Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France

Br J Cancer. 1995 Nov;72(5):1278-82. doi: 10.1038/bjc.1995.500.


Treatment and survival rates of patients with non-small-cell lung cancer (NSCLC) were compared between three French Cancer Registries (Calvados, Doubs, Tarn). The methodological issues in such comparisons are discussed. The treatments for NSCLC differed between the regions: radiotherapy tended to be preferred in Calvados (73% vs 21.3% surgery), whereas surgery was more frequently employed in Doubs and Tarn (27.7% and 37% respectively). The percentage of cases receiving no therapeutic treatment ranged from 7.8% (Calvados) to 26% (Tarn). Despite the differences in treatment, the overall survival rates were similar in the three regions. Adjustment for treatment in such a descriptive study may be misleading since different therapeutic strategies in different regions may lead to selection of patients of systematically better or poorer prognosis in the various treatment groups.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bronchial Neoplasms / mortality
  • Bronchial Neoplasms / therapy
  • Carcinoma, Non-Small-Cell Lung / mortality*
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Female
  • France / epidemiology
  • Humans
  • Lung Neoplasms / mortality*
  • Lung Neoplasms / radiotherapy
  • Lung Neoplasms / surgery
  • Lung Neoplasms / therapy*
  • Male
  • Middle Aged
  • Patient Selection
  • Pneumonectomy / statistics & numerical data
  • Prognosis
  • Radiotherapy / statistics & numerical data
  • Registries
  • Survival Analysis
  • Survival Rate